-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
TC BioPharm (Holdings) plc quarterly/annual Amortization of Intangible Assets history and change rate from 2022 to 2024.
- TC BioPharm (Holdings) plc Amortization of Intangible Assets for the quarter ending 31 Mar 2024 was £12.3K, a 3.9% increase year-over-year.
- TC BioPharm (Holdings) plc annual Amortization of Intangible Assets for 2024 was £50.7K, a 39.7% increase from 2023.
- TC BioPharm (Holdings) plc annual Amortization of Intangible Assets for 2023 was £36.3K, a 34.1% decline from 2022.
Amortization of Intangible Assets, Quarterly (GBP)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (GBP)
Amortization of Intangible Assets, YoY Annual Change (%)